Vinay Shah Net Worth

The estimated Net Worth of Vinay Shah is at least $658 Thousand dollars as of 29 June 2021. Mr. Shah owns over 1,000 units of Aravive Inc stock worth over $7,634 and over the last 6 years he sold ARAV stock worth over $0. In addition, he makes $650,038 as Chief Financial Officer at Aravive Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Shah ARAV stock SEC Form 4 insiders trading

Vinay has made over 2 trades of the Aravive Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of ARAV stock worth $5,310 on 29 June 2021.

The largest trade he's ever made was buying 8,000 units of Aravive Inc stock on 4 December 2020 worth over $46,080. On average, Vinay trades about 1,500 units every 34 days since 2019. As of 29 June 2021 he still owns at least 190,842 units of Aravive Inc stock.

You can see the complete history of Mr. Shah stock trades at the bottom of the page.

Vinay Shah biography

Vinay Shah serves as Chief Financial Officer of the Company. Mr. Shah also served as the Chief Financial Officer of Private Aravive since 2010, initially as a consultant and from 2017 as an employee. Mr. Shah brings more than 18 years of financial management experience in the medical device and biopharmaceutical industries to our company. From 2008 until 2016, he served in various positions at Pacira Pharmaceuticals Inc., a specialty pharmaceutical company, including Executive Director of Finance and Executive Director of Strategy Analytics, initially as a consultant and since 2010 as an employee. Before Pacira Pharmaceuticals Inc., Mr. Shah worked for Cardinal Health’s medical device group in various finance management positions. The group was subsequently consolidated and spun off as CareFusion and then sold to Becton, Dickinson and Company. His prior work experience includes positions at Pricewaterhouse Coopers LLP (“PwC”) and KPMG in India and the Middle East. Mr. Shah received a Bachelor of Commerce degree from Ranchi University in India.

What is the salary of Vinay Shah?

As the Chief Financial Officer of Aravive Inc, the total compensation of Vinay Shah at Aravive Inc is $650,038. There are 1 executives at Aravive Inc getting paid more, with Gail McIntyre having the highest compensation of $713,495.

How old is Vinay Shah?

Vinay Shah is 58, he's been the Chief Financial Officer of Aravive Inc since 2018. There are 4 older and 5 younger executives at Aravive Inc. The oldest executive at Aravive Inc is Fredric Eshelman, 72, who is the Independent Chairman of the Board.

What's Vinay Shah's mailing address?

Vinay's mailing address filed with the SEC is C/O ARAVIVE, INC., RIVER OAKS TOWER,, 3730 KIRBY DRIVE, SUITE 1200, HOUSTON, TX, 77098.

Insiders trading at Aravive Inc

Over the last 6 years, insiders at Aravive Inc have traded over $107,045 worth of Aravive Inc stock and bought 151,333 units worth $1,102,898 . The most active insiders traders include Srinivas Akkaraju, Fredric N Eshelman Ventures..., and Shahzad Malik. On average, Aravive Inc executives and independent directors trade stock every 75 days with the average trade being worth of $11,962. The most recent stock trade was executed by Fredric N Eshelman Ventures... on 1 April 2022, trading 4,545,455 units of ARAV stock currently worth $181,818.

What does Aravive Inc do?

versartis, inc. (nasdaq: vsar) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. the company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. versartis’ mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. learn more at www.versartis.com.

Complete history of Mr. Shah stock trades at Aravive Inc

Aravive Inc executives and stock owners

Aravive Inc executives and other stock owners filed with the SEC include:

• Gail McIntyre,
  President, Chief Executive Officer, Director
• Vinay Shah,
  Chief Financial Officer
• Dr. Gail F. McIntyre CH (ASCP), DABT, Ph.D.,
  Pres, CEO & Director
• Dr. Reshma Rangwala M.D., Ph.D.,
  Chief Medical Officer
• Amato Giaccia,
  Independent Director
• Raymond Tabibiazar,
  Independent Director
• Eric Zhang,
  Independent Director
• Dr. Fredric N. Eshelman Pharm.D.,
  Exec. Chairman
• Mike Zanoni,
  IR Contact Officer
• Michael Rogers,
  Director
• Reshma Rangwala,
  Chief Medical Officer
• Fredric Eshelman,
  Independent Chairman of the Board
• Kenneth L. Guernsey,
  Sec.
• Dr. Randy L. Anderson,
  Sr. VP of Data Sciences
• Joseph T. Schepers,
  VP of Investor Relations
• Dr. Joshua Silverman Ph.D.,
  Co-Founder
• Dr. Jeffrey L. Cleland,
  Co-Founder
• Maria Carolina Petrini,
  Chief Commercial Officer
• Robert B. Geller,
  Chief Medical Officer
• Leonard Scott Dove,
  Chief Operating Officer
• Rekha Hemrajani,
  
• Srinivas Akkaraju,
  Director
• Jay Shepard,
  President and CEO
• Kevin Haas,
  VP, Finance and PAO
• Shahzad Malik,
  Director
• Robert Hoffman,
  Director
• Peter Tai Ching Ho,
  Director
• John Hohneker,
  Director
• Sigurd Kirk,
  Director
• Rudy Howard,
  Chief Financial Officer